MyPath Melanoma and DiffDx-Melanoma are validated to more accurately diagnose lesions of unknown malignant potential as benign, intermediate, or malignant. This provides information to your physician that allows them to make a more confident diagnosis, follow-up, and treatment plan.
Twelve published studies
MyPath Melanoma or DiffDx-Melanoma May Be Right for You
Talk to your healthcare provider and healthcare team to learn more about how MyPath Melanoma or DiffDx-Melanoma test results can be used to help better diagnose your lesion to personalize your treatment and ongoing management.